Today the FDA granted marketing authorization for a new device indicated to provide continuous hemodialysis or hemofiltration therapy to critically ill pediatric patients with certain kidney conditions. https://go.usa.gov/xvmz4 pic.twitter.com/yt8wD9JLfU
Today the FDA granted marketing authorization for a new device indicated to provide continuous hemodialysis or hemofiltration therapy to critically ill pediatric patients with certain kidney conditions. https://go.usa.gov/xvmz4 pic.twitter.com/yt8wD9JLfU
Source: Food and Drug Adminstration (FDA): CDRHNew - Category: Medical Devices Authors: ( at FDAMedia) Source Type: news
More News: Dialysis | Hemodialysis | Hemofiltration | Marketing | Medical Devices | Pediatrics | Urology & Nephrology